Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;23(9):1437-1444.
doi: 10.1002/ejhf.2248. Epub 2021 Jun 16.

Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative?

Harriette G C Van Spall  1   2   3 , Tauben Averbuch  1 , Kevin Damman  4 , Adriaan A Voors  4
Affiliations
Free article

Risk and risk reduction in trials of heart failure with reduced ejection fraction: absolute or relative?

Harriette G C Van Spall et al. Eur J Heart Fail. 2021 Sep.
Free article
No abstract available

PubMed Disclaimer

References

    1. Van Spall HG, Averbuch T, Lee SF, Oz UE, Mamas MA, Louis Januzzi J Jr, Dennis T Ko. The LENT index predicts 30 day outcomes following hospitalization for heart failure. ESC Heart Fail 2021;8:518-526.
    1. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (COPERNICUS). N Engl J Med 1987;316:1429-1435.
    1. Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN; SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:303-310.
    1. Gheorghiade M, Larson CJ, Shah SJ, Greene SJ, Cleland JGF, Colucci WS, Dunnmon P, Epstein SE, Kim RJ, Parsey RV, Stockbridge N, Carr J, Dinh W, Krahn T, Kramer F, Wahlander K, Deckelbaum LI, Crandall D, Okada S, Senni M, Sikora S, Sabbah HN, Butler J. Developing new treatments for heart failure: focus on the heart. Circ Heart Fail 2016;9:e002727.
    1. Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O'Connor CM; VICTORIA Study Group. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 2020;382:1883-1893.